Advertisement
Singapore markets closed

  • Straits Times Index

    3,144.76
    -38.85 (-1.22%)
     

  • S&P 500

    5,061.82
    -61.59 (-1.20%)
     

  • Dow

    37,735.11
    -248.13 (-0.65%)
     

  • Nasdaq

    15,885.02
    -290.08 (-1.79%)
     

  • Bitcoin USD

    62,962.24
    -3,230.39 (-4.88%)
     

  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     

  • FTSE 100

    7,868.78
    -96.75 (-1.21%)
     

  • Gold

    2,389.50
    +6.50 (+0.27%)
     

  • Crude Oil

    84.84
    -0.57 (-0.67%)
     

  • 10-Yr Bond

    4.6280
    0.0000 (0.00%)
     

  • Nikkei

    38,471.20
    -761.60 (-1.94%)
     

  • Hang Seng

    16,248.97
    -351.49 (-2.12%)
     

  • FTSE Bursa Malaysia

    1,535.00
    -7.53 (-0.49%)
     

  • Jakarta Composite Index

    7,164.81
    -122.07 (-1.68%)
     

  • PSE Index

    6,404.97
    -157.46 (-2.40%)
     

Rite Aid (RAD) Moves 7.9% Higher: Will This Strength Last?

Zacks Equity Research
·2-min read

Rite Aid RAD shares ended the last trading session 7.9% higher at $8.23. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the stock's 13.2% gain over the past four weeks.

Rumors of Rite Aid becoming a target for activist investors stemming from speculations of management changes has send the stock soaring. The company has been delivering great customer service via accelerated COVID-19 vaccine program and the expansion of delivery services. Strength in its PBM business driven by its RxEvolution strategy bodes well. It also remains focused on providing lower healthcare costs, better customer engagement and personalized services.

This drugstore chain is expected to post quarterly loss of $0.56 per share in its upcoming report, which represents a year-over-year change of -36.6%. Revenues are expected to be $5.77 billion, down 5.6% from the year-ago quarter.

Earnings and revenue growth expectations certainly give a good sense of the potential strength in a stock, but empirical research shows that trends in earnings estimate revisions are strongly correlated with near-term stock price movements.

ADVERTISEMENT

For Rite Aid, the consensus EPS estimate for the quarter has remained unchanged over the last 30 days. And a stock's price usually doesn't keep moving higher in the absence of any trend in earnings estimate revisions. So, make sure to keep an eye on RAD going forward to see if this recent jump can turn into more strength down the road.

The stock currently carries a Zacks Rank #3 (Hold). You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>

Rite Aid belongs to the Zacks Retail - Pharmacies and Drug Stores industry. Another stock from the same industry, CVS Health CVS, closed the last trading session 0.2% higher at $95.68. Over the past month, CVS has returned 3.1%.

CVS Health's consensus EPS estimate for the upcoming report has changed -2.1% over the past month to $2.16. Compared to the company's year-ago EPS, this represents a change of -10.7%. CVS Health currently boasts a Zacks Rank of #3 (Hold).


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Rite Aid Corporation (RAD) : Free Stock Analysis Report
 
CVS Health Corporation (CVS) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research